Freiburg, Germany

Monika Lusky

This inventor holds 4 USPTO granted patents. Top assignee: Transgene S.a.. Active years: 2000-2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Monika Lusky. Retrieved from https://idiyas.com/inventor/monika-lusky

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.4

ph-index = 2

Forward Citations = 55(Granted Patents)


Location History:

  • Freiburg, DE (2000 - 2002)
  • Frieburg, DE (2002)

Company Filing History:


Years Active: 2000-2002

Loading Chart...
4 patents (USPTO):Explore Patents

Title: **Innovator Monika Lusky: Pioneering Advances in Gene Therapy**

Introduction

Monika Lusky, a notable inventor based in Freiburg, Germany, has made significant contributions to the field of gene therapy through her innovative work and inventions. With four patents to her name, her research has garnered attention in the biotechnology sector, particularly in the development of adenoviral vectors for therapeutic applications.

Latest Patents

Among her latest inventions, Monika has developed **Chimeric Adenoviral Vectors**. This invention revolves around creating adenoviral vectors that contain essential regions for heterologous packaging associated with their respective adenoviral genomes. The patent also describes a method for producing viral preparations that incorporate these vectors, which can serve various therapeutic or prophylactic purposes.

Another remarkable invention is the patent concerning **Helper Viruses for the Preparation of Recombinant Viral Vectors**. This technology features novel helper vectors designed to complement defective recombinant viral vectors. These vectors include recombination sequences that can be recognized by a recombinase, allowing for the creation of infectious viral particles aimed at delivering and expressing genes of interest within a host.

Career Highlights

Monika Lusky's career is marked by her commitment to advancing the science of virology and gene therapy. Her work at Transgene S.A., a company dedicated to the development of innovative immunotherapies for the treatment of cancer and infectious diseases, reflects her expertise and commitment to improving therapeutic outcomes.

Collaborations

Throughout her career, Monika has collaborated with esteemed colleagues, including Majid Mehtali and Karola Rittner, whose partnerships have facilitated the advancement of her research projects and patents. Their collective efforts underscore the importance of teamwork in driving innovation within the biomedical field.

Conclusion

With her groundbreaking inventions and the continued pursuit of advancements in gene therapy, Monika Lusky stands out as a pioneering inventor in her field. Her work not only contributes to scientific knowledge but also has the potential to change lives through innovative therapeutic applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…